PLEXIUM
Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases. Plexium's platform focuses on the discovery of next-generation TPD drugs that extend beyond the limited applications of Proteolysis Targeting Chimeras (PROTACs) and cereblon imids, unraveling the boundless possibilities of true drug-like protein degraders. From molecular glues to monovalent degraders, the possibilities are endless across a wide variety of therapeutic areas.
PLEXIUM
Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.plexium.com
Total Employee:
51+
Status:
Active
Total Funding:
165 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics LetsEncrypt
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Aro Biotherapeutics
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Capital Rx
Capital Rx is a healthtech platform that provides pharmacy benefit management solutions.
Castor
Castor offers a cloud-based clinical data platform that simplifies and streamlines clinical trials processes.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
H1.co
H1 provides a health data platform to support the end-to-end therapeutic development process of medical companies and healthcare systems.
Ophelia
Ophelia offers medication and support for quitting opioids.
Traya Health
Traya Health offers a treatment platform that targets hair loss through a combination of Ayurvedic medicine, nutrition and allopathy.
Current Advisors List
Current Employees Featured
Founder
Investors List
CRV
CRV investment in Series B - Plexium
RA Capital Management
RA Capital Management investment in Series B - Plexium
Pappas Capital
Pappas Capital investment in Series B - Plexium
DCVC Bio
DCVC Bio investment in Series B - Plexium
SoftBank Vision Fund
SoftBank Vision Fund investment in Series B - Plexium
Pivotal bioVenture Partners
Pivotal bioVenture Partners investment in Series B - Plexium
M Ventures
M Ventures investment in Series B - Plexium
Surveyor Capital
Surveyor Capital investment in Series B - Plexium
Lux Capital
Lux Capital investment in Series B - Plexium
Neotribe Ventures
Neotribe Ventures investment in Series B - Plexium
Key Employee Changes
Official Site Inspections
http://www.plexium.com Semrush global rank: 4.26 M Semrush visits lastest month: 2.31 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Plexium"
Plexium - Crunchbase Company Profile & Funding
Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases. Plexium's platform focuses on the discovery of next-generation TPD drugs that extend beyond the limited applications of …See details»
Plexium - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Seed Round - Plexium . 1: …See details»
Plexium - LinkedIn
Plexium is the premier, next-generation targeted protein degradation company, seeking to discover a wide range of monovalent target protein degraders that address the limitations of PROTACs and ...See details»
Plexium Company Profile 2024: Valuation, Funding
Plexium General Information Description. Developer of protein-degrading therapeutics designed to treat cancer and other serious diseases. The company identifies novel small molecules that redirect ligases to targets of interest or …See details»
Stephen Mullennix - Chief Financial Officer - Plexium, Inc.
Stephen joined Plexium from ProSciento, Inc., a leading Clinical Research Organization in the metabolic disease arena, where he served as CFO. Prior to ProSciento, Mr. Mullennix was CFO and COO of UroGen Pharma, Ltd …See details»
Plexium - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Plexium . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 5. Number of Board …See details»
Plexium, Inc. Company Profile | San Diego, CA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Plexium, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Plexium - The Org
Plexium is a pharmaceutical company developing first-in-class therapeutics by modulating E3 ligases. Industries. PharmaceuticalSee details»
Plexium - Work in biotech
Plexium is advancing developments in targeted protein degradation (TPD). By using their proprietary ultra-high-throughput cell-based (uHTS) screening technology, Plexium is detecting …See details»
Contact Plexium - San Diego CA
Please contact us to learn more about our platform and diversified pipeline of wholly-owned and partnered programs.See details»
Plexium, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
I believe that Plexium is well positioned for success with the recent advancement of PLX-4545 into Phase 1 and the advancing preclinical pipeline of small molecule monovalent degraders of …See details»
Plexium, Inc. (Plexium, Inc.) - 药物管线_专利_临床试验_投融营收_最 …
了解Plexium, Inc. (Plexium, Inc.)公司的药物管线，治疗领域，技术平台，以及它的28篇新闻和1篇文献，疾病领域:肿瘤，内分泌与代谢疾病，技术平台:分子胶，蛋白水解靶向嵌合 …See details»
Plexium - Crunchbase
Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.See details»
The Column Group - Plexium, Inc.
Get in Touch [email protected] 9330 Scranton Road, Suite 500 San Diego, CA 92121See details»
Plexium Reviews: What Is It Like to Work At Plexium?
Dec 21, 2022 As in every research organization in this industry there are those who are smarter than everyone else and a few bad apples have gotten through the filtering process. The …See details»
PLEXIUM STRENGTHENS LEADERSHIP TEAM WITH APPOINTMENT …
SAN DIEGO, Aug. 24, 2022 /PRNewswire/ -- Plexium, Inc. (Plexium), a leading next-generation targeted protein degradation (TPD) company, today announced the appointment of Daniel …See details»
Plexium Launches with $28 Million in Series A Financing
Oct 17, 2019 Funds will help advance Plexium’s DELPhe platform to discover novel E3 ligase-modulating therapeutics to treat cancer and neurodegenerative diseases. SAN DIEGO, …See details»
Discovery of novel small molecules that recruit DCAF11 for
Plexium, San Diego, CA. [email protected]. Abstract. PLX-3618 elicits potent anti-tumor activity . in vivo. Plexium’s screening platform and initial hit identification, validation, and …See details»
Plexium's Limitless Pipeline - A Diverse Portfolio Strategy
Plexium's Pipeline. A Targeted Therapy-Based Portfolio Strategy. Programs. Discovery; Lead Optimization; IND-Enabling; Phase 1; PLX-4545 (IKZF2) Molecular Glue (Cereblon) Indication. …See details»